Business Context and Reporting Period
This Form 8-K is filed by Greatbatch, Inc. (not Integer Holdings Corp) for the reporting period of October 25, 2005. The filing discloses the entry into a material definitive agreement with Medtronic, Inc.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses on the terms of a new licensing agreement rather than reporting period financial results.
Material Changes
On October 25, 2005, Greatbatch, Inc. entered into a perpetual license agreement with Medtronic, Inc. granting Medtronic the right to use certain intellectual property related to tantalum capacitors. Key terms include:
- The license is exclusive to Medtronic, except for Greatbatch's right to manufacture and sell capacitors.
- Compensation includes an initial license fee (due after Medtronic's first U.S. sale) and ongoing royalties.
- Greatbatch is required to pay a portion of the royalties to a third party.
- Royalties are subject to a maximum cap and may be eliminated if Medtronic purchases a specified percentage of its tantalum capacitor requirements from Greatbatch.
Outlook, Risks, and Management Commentary
Management explicitly states that the Company cannot provide assurances that Medtronic will utilize the licensed capacitor technology or purchase any capacitors. The agreement creates a potential revenue stream contingent on Medtronic's future sales and purchasing decisions.
Investor Verification Checklist
- Verify the exact timing and amount of the initial license fee payment.
- Confirm the specific percentage of capacitor purchases required to eliminate royalties.
- Identify the third party to whom Greatbatch must pay a portion of the royalties.
- Monitor future filings for confirmation of Medtronic's first U.S. sale under the agreement.